Literature DB >> 6273318

Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

N Kirmani, R K Ginn, K K Mittal, J F Manischewitz, G V Quinnan.   

Abstract

The cytotoxicity of circulating mononuclear cells from normal volunteers was determined using human leukocyte antigen (HLA)-typed, low-passaged human skin fibroblasts infected with cytomegalovirus as target cells. Peripheral blood lymphocytes from both seropositive and seronegative individuals possessed virus specific cytotoxicity. Although all target cells used were susceptible to virus specific lysis, lymphocytes from some individuals were more active against some target cells than others. This differential cytotoxicity did not follow a consistent pattern of HLA restriction. Some variations in cytotoxic activity were noted on sequential studies of individual volunteers. Studies of fractionated lymphocytes from selected immune and nonimmune individuals demonstrated that cytotoxicity of lymphocytes from both groups was mediated by nonadherent, Fc receptor bearing cells which did not form rosettes with sheep erythrocytes. Repeated washing sometimes decreased cytotoxicity of lymphocytes from immune individuals, and addition of serum containing antibody to cytomegalovirus enhanced cytotoxicity, suggesting antibody dependence. It is concluded that cytotoxic lymphocytes from nonimmune volunteers possessed characteristics of natural killer cells, whereas those from immune volunteers probably consisted of both natural killer cells and antibody-dependent killer cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273318      PMCID: PMC350886          DOI: 10.1128/iai.34.2.441-447.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.

Authors:  U Koszinowski; H Ertl
Journal:  Nature       Date:  1975-06-12       Impact factor: 49.962

2.  Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.

Authors:  Y H Thong; S A Hensen; M M Vincent; D A Fuccillo; W A Stiles; J A Bellanti
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  Lysis of cytomegalovirus-infected human fibroblasts and transformed human cells by peripheral blood lymphoid cells from normal human donors.

Authors:  R D Diamond; R Keller; G Lee; D Finkel
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

4.  Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1.

Authors:  I Heron; A Moller-Larsen; K Berg
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

6.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

7.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

8.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

9.  Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.

Authors:  I Royston; J L Sullivan; P O Periman; E Perlin
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

10.  Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus.

Authors:  M Rola-Pleszczynski; L D Frenkel; D A Fuccillo; S A Hensen; M M Vincent; D W Reynolds; S Stagno; J A Bellanti
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  5 in total

1.  Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus.

Authors:  S Bandyopadhyay; S H Oh; S Michelson; D S Miller; J L Virelizier; S E Starr
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

2.  Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.

Authors:  R C Gehrz; S R Rutzick
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

3.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.

Authors:  S Bandyopadhyay; B Perussia; G Trinchieri; D S Miller; S E Starr
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

5.  Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.

Authors:  G A Bishop; J C Glorioso; S A Schwartz
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.